Butterfly Medical has developed a fast, non-invasive alternative treatment to first-line benign prostate hyperplasia medication & surgery.
Butterfly Medical has raised €5.9M across 1 funding round from 1 investor, most recently a Series B round in Oct 2020. Based in Yoqne`am `illit, Israel; founded 2014; active in Healthtech. Data as of 7 Aug 2026.
Timing: dormant vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2020-10-06 | Series B |
| €5.9M |
| New Rhein Healthcare |
| View deal → |
